Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Major redesign of the trial: the arms shift to CP backbone with three arms (CP+P+O, CP+P, CP), new location/registry details added, and results posting status updated to 2025-09-12.
    Difference
    22%
    Check dated 2025-09-13T17:39:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T15:19:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The webpage has been updated to include new drug information for various treatments, including Pembrolizumab and Olaparib, and has added numerous specific location details across multiple countries. Additionally, some previously listed locations and drug information have been removed.
    Difference
    19%
    Check dated 2025-08-30T11:57:39.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.0%
    Check dated 2025-08-16T04:41:01.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-08T23:54:14.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.3%
    Check dated 2025-08-01T19:28:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.